PhRMA/RxHealth
Executive Summary
September meeting between Pharmaceutical Research & Manufacturers of America health outcomes committee and the RxHealth Value coalition was a general get acquainted session, PhRMA said. The pharmaceutical trade association has no plans to provide information to RxHealth for specific outcomes studies. RxHealth Value Executive Director John Golenski mentioned the meeting with PhRMA during a National Institute for Health Care Management conference Sept. 25 (1"The Pink Sheet" Oct. 16, p. 11)